CONTACT US

Meet the physIQ experts! 

The DIA Annual Meeting

June 20 - 22 | Chicago

Booth #2445

Attending DIA? Meet with physIQ to learn how wearable sensors and digital biomarkers are the key to measuring drug effectiveness, enhancing patient safety and outcomes, and reducing study risk.

IQ Banner Rectangle

The DIA Exhibition Begins In...

00

days

00

hours

00

minutes

00

seconds

move from Drug efficacy to effectiveness

physIQ simplifies the collection of continuous biometric data from wearable devices in the real world and uses AI-based digital biomarkers to deliver actionable clinical insights so you can make better decisions and produce better outcomes. 

Enabling The Life Sciences to Healthcare Continuum

To support payer and provider needs, life sciences are investing significant efforts in post approval settings to generate evidence to support effectiveness of their therapeutics which represents a shift from traditional efficacy.

AI Assisted Continuous Assessment of Remote Endpoints

Continuous safety monitoring leveraging PhysIQ’s patented MCI digital biomarker as well as other dBM assets such as EVO2Max and Inflammation.

Next Generation Digital Biomarkers

Existing digital biomarker and future digit biomarker development capabilities.

Reported Outcomes

physIQ’s unique ability to incorporate performance, patient, observer and clinician report outcomes into the digital stream.

Wearable Device Optimization

Unique understanding of how biology and physiology can be best described using devices and insights generated by AI based digital endpoints.

 

Schedule TIme with an Expert

 

Meet with

John Varaklis

John Veraklis

As physIQ’s Chief Strategy Officer, John brings extensive experience in Global Clinical Development having led early and late-phase Clinical Operations at Novartis, Abbott and Roche.

As a pioneer in direct from patient data capture approaches, John’s innovation team led the implementation of the first wireless remote endpoint collections solutions at Novartis and was awarded a patent for this novel work. 

 

 

 

IT'S TIME TO TAKE ACTION.

CONTACT PHYSIQ TODAY. 

CONTACT US